Public Health
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Global pharma insights on public health trends, policy shifts, and disease epidemiology. Inform your investment & BD strategy with critical intelligence.
Showing 1–12 of 16 articles
Quick answer
NovaPharmaNews Public Health hub for FDA covers 16 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Chile warning labels on food: new evidence on efficacy and obesity risk
CDC data show alcohol use during pregnancy is rising again
Obesity rates in America by year: what the data shows
Ebola 2026: US Response and Travel Restrictions Debate
Senior NIH official pushes MAHA strategy to skeptical ADA audience
Opinion: The Amish Way of Healthcare Offers Lessons for Public Health
Ultra-Processed Food Policy Demands Escalate as Researchers Cite Systemic Issues
Trump's Executive Order on Childhood Vaccine Schedules: Impact on Pharmaceutical Companies
CDC Prioritizes Ebola Containment, Highlighting Critical Role of Clinical Trials
APHL 2026 Annual: Day 1 Key Takeaways
APHL 2026 Annual: Day 1 Highlights & Key Takeaways
APHL 2026 Annual Meeting: Day 1 Highlights
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.